» Articles » PMID: 10602341

Tetrandrine Ameliorates Ischaemia-reperfusion Injury of Rat Myocardium Through Inhibition of Neutrophil Priming and Activation

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1999 Dec 22
PMID 10602341
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

1. We have previously shown that tetrandrine (TTD), a bisbenzyltetrahydroiosquinoline isolated from the Chinese herb Stephania tetrandra, inhibits neutrophil adhesion, Mac-1 expression, and reactive oxygen species (ROS) production. To examine whether inhibition of neutrophil function may confer upon TTD the ability to prevent myocardial ischaemia-reperfusion (MI/R) injury, experiments were performed on rats subjected to coronary ligation followed by reperfusion for induction of MI/R injury. 2. Intravenous administration of TTD (0.1 and 1.0 mg kg-1) 15 min prior to coronary ligation completely prevented MI/R-associated mortality. TTD pretreatment also significantly reduced MI/R-induced ventricular tachyarrhythmia, myocardial infarct size, and neutrophil infiltration. 3. However, TTD pretreatment did not influence mean arterial blood pressure, heart rate, or product of pressure-rate, indicating that TTD extenuated MI/R through mechanisms independent of modulating haemodynamics or myocardial oxygen demand. 4. Peripheral blood neutrophils were isolated for ex vivo examination of shape change and Mac-1 upregulation of neutrophils, two sensitive indicators of proinflammatory priming, as well as N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced adhesion and ROS production, parameters commonly used for the assessment of neutrophil activation. 5. Neutrophils from MI/R animals showed significant shape change and Mac-1 upregulation, both of which were prevented by TTD-pretreatments. On the other hand, fMLP-induced adhesion and ROS production of neutrophils were markedly enhanced by MI/R but diminished in TTD-pretreated animals. 6. These data suggest that the protective effect of TTD against MI/R injury can be accounted for by inhibition of neutrophil priming and activation, thereby abolishing subsequent infiltration and ROS production that cause MI/R injury.

Citing Articles

Insights on exploring the therapeutic potential and structural modification of Tetrandrine.

Gong L, Liu H, Xu B, Yu T, Wang Y, Niu S Future Med Chem. 2024; 16(24):2687-2700.

PMID: 39606807 PMC: 11731063. DOI: 10.1080/17568919.2024.2432297.


Immuno-inflammatory pathogenesis in ischemic heart disease: perception and knowledge for neutrophil recruitment.

Wang Y, Shou X, Wu Y, Li D Front Immunol. 2024; 15:1411301.

PMID: 39050842 PMC: 11266024. DOI: 10.3389/fimmu.2024.1411301.


Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated.

Li T, Yan Z, Fan Y, Fan X, Li A, Qi Z Front Cardiovasc Med. 2023; 9:1077290.

PMID: 36698953 PMC: 9868426. DOI: 10.3389/fcvm.2022.1077290.


Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase.

Wang Y, Cai X, Wu Z, Tang L, Lu L, Xu Y Mol Med Rep. 2021; 23(4).

PMID: 33649825 PMC: 7930946. DOI: 10.3892/mmr.2021.11936.


A critical review: traditional uses, phytochemistry, pharmacology and toxicology of S. Moore (Fen Fang Ji).

Jiang Y, Liu M, Liu H, Liu S Phytochem Rev. 2020; 19(2):449-489.

PMID: 32336965 PMC: 7180683. DOI: 10.1007/s11101-020-09673-w.


References
1.
Haston W, van Duzer J, Quintavalla J . Flow cytometric assessment of NADPH oxidase inhibitors in whole blood. Inflamm Res. 1995; 44 Suppl 2:S155-7. DOI: 10.1007/BF01778309. View

2.
Shen Y, Chen C, Wang S, Sung Y . Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 Up-regulation and adhesion by tetrandrine. Mol Pharmacol. 1999; 55(1):186-93. DOI: 10.1124/mol.55.1.186. View

3.
Go L, Murry C, Richard V, Weischedel G, Jennings R, Reimer K . Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. Am J Physiol. 1988; 255(5 Pt 2):H1188-98. DOI: 10.1152/ajpheart.1988.255.5.H1188. View

4.
Stahl G, Terashita Z, Lefer A . Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther. 1988; 244(3):898-904. View

5.
Walker M, Curtis M, Hearse D, CAMPBELL R, Janse M, Yellon D . The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988; 22(7):447-55. DOI: 10.1093/cvr/22.7.447. View